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ABSTRACT 
BTB-Kelch proteins are substrate-specific 
adaptors for cullin-3 (Cul3) RING-box–based 
E3 ubiquitin ligases, mediating protein 
ubiquitylation for subsequent proteasomal 
degradation. Vaccinia virus encodes three BTB-
Kelch proteins: A55, C2, and F3. Viruses 
lacking A55 or C2 have altered cytopathic 
effects in cultured cells and altered pathology in 
vivo. Previous studies have shown that the 
ectromelia virus orthologue of A55 interacts 
with Cul3 in cells. We report that the N-terminal 
BTB-BACK (BB) domain of A55 binds directly 
to the Cul3 N-terminal domain (Cul3-NTD), 
forming a 2:2 complex in solution. We solved 
the structure of an A55BB/Cul3-NTD complex 
from anisotropic crystals diffracting to 2.3/3.7 Å 
resolution in the best/worst direction, revealing 
that the overall interaction and binding interface 
closely resembles the structures of cellular 
BTB/Cul3-NTD complexes, despite low 
sequence identity between A55 and cellular BTB 
domains. Surprisingly, despite this structural 
similarity, the affinity of Cul3-NTD for A55BB 
was stronger than for cellular BTB proteins. 
Glutamate substitution of A55 residue Ile 48, 
adjacent to the canonical ϕ-X-D/E Cul3-binding 
motif, reduced affinity of A55BB for Cul3-NTD 
by at least two orders of magnitude. Moreover, 
Ile 48 and the ϕ-X-D/E motif are conserved in 
A55 orthologs from other poxviruses, but not in 
the vaccinia virus proteins C2 or F3. The high-
affinity interaction between A55BB and Cul3-
NTD suggests that, in addition to directing the 
Cul3–RING E3 ligase complex to degrade 
cellular/viral target proteins that are normally 
unaffected, A55 may also sequester Cul3 from 
cellular adaptor proteins, thereby protecting 
substrates of these cellular adaptors from 
ubiquitylation and degradation. 
 
 
Vaccinia virus (VACV) is a double-stranded 
DNA virus in the Orthopoxvirus genus of the 
Poxviridae. Historically VACV was used as the 
vaccine to eradicate smallpox (1). Its genome 
contains approximately 200 genes, about half of 
which are involved in the modulation of host 
immune response to viral infection, and the virus 
has been used as a model system to study innate 
immunity (2). The mechanisms by which several 
VACV proteins act to inhibit innate immune 
sensing and effector function, especially those 
involved in the inhibition of NF-κB signalling, 
have been well characterized (2,3). Nevertheless, 
many VACV immunomodulatory proteins are 
still poorly understood and one such protein is 
A55.  
A55 is an intracellular protein encoded by the 
A55R gene of VACV (4). It belongs to the BTB 
(Bric-a-brac, Tramtrack and Broad-complex)-
Kelch protein family, which are substrate 
adaptor proteins specific for the cullin-3 (Cul3)-
RING (Really Interesting New Gene) based E3 
ubiquitin ligase (C3RL) complex (5). The N-
terminal region of these proteins contains a BTB 
domain that mediates dimerization and binding 
to Cul3, a 3-box helical bundle region, and a 
BACK (for BTB and C-terminal Kelch) domain 
that is likely responsible for correctly orientating 
the C terminus (5-13). The C-terminal region 
comprises 4-6 Kelch repeats arranged into a 
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single β-propeller that captures the substrates for 
the C3RL complex; alternatively, these Kelch 
domains may also interact with actin filaments to 
regulate cytoskeleton organisation (5,9-11,14-
19). In cells, there are many BTB-domain-
containing proteins conjugated with different 
substrate recognition domains and their 
interactions with various substrates and C3RL 
complexes are implicated in several cellular 
processes including protein degradation, 
transcriptional regulation (KEAP1), the gating 
of voltage-gated potassium channels (KCTDs), 
and cytoskeleton modulation (KLHLs) (19-25). 
Apart from mimiviruses, poxviruses are the only 
family of viruses that make BTB domain-
containing proteins (26-30).  
Deletion of A55 from VACV does not 
diminish virus replication in cultured cells (4). 
However, cells infected with VACV lacking 
A55 (vΔA55) demonstrated altered cytopathic 
effects, including the loss of Ca2+-independent 
cell adhesion and cellular projections, 
suggesting that A55 plays a role in the 
modulation of the cytoskeleton (4). The use of an 
intradermal murine model of infection 
demonstrated that infection with vΔA55 caused 
increased lesion size compared with wild-type 
virus, suggesting that A55 plays a role in altering 
the host immune response in vivo (4).  
VACV encodes three BTB-Kelch proteins, 
namely A55, C2 and F3. Despite having similar 
domain organizations, A55 shares limited 
sequence identity with C2 and F3 (22% and 25%, 
respectively). Like A55, C2 and F3 are 
dispensable for VACV replication in cultured 
cells (31,32). Infection of cells with vΔA55 or 
with VACV lacking C2 (vΔC2) produced a 
similar loss of Ca2+-independent cell adhesion, 
suggesting that A55 and C2 affect similar 
cellular pathways (4,31). However, intradermal 
infection in vivo with vΔC2 resulted in similar-
sized lesions to wild-type infection but these 
lesions persisted for longer, distinct from the 
phenotype observed for vΔA55 (4,31). Infection 
with VACV lacking F3 (vΔF3) produced no 
distinct phenotype in cultured cells but 
intradermal infection yielded smaller lesions 
compared to wild-type virus (32). These results 
suggest that VACV BTB-Kelch proteins are 
functionally divergent despite having a 
conserved domain organization. 
C3RLs are a family of multi-modular cullin-
RING based E3 ubiquitin ligases that recruit 
substrates specifically via BTB-domain 
containing adaptor proteins (5,6). Cul3, the all-
helical stalk-like scaffold subunit of C3RLs, 
interacts directly with BTB-domain-containing 
proteins via its N-terminal domain (6-
8,13,24,33). The C-terminal domain of Cul3 
interacts with the RING based E3 ligase protein 
to recruit the ubiquitin-loaded E2-conjugating 
enzyme for substrate ubiquitylation and is 
dispensable for binding to BTB-domain proteins 
(5,11,34). Crystal structures of several cellular 
BTB-domain proteins in complex with the Cul3 
N-terminal domain (Cul3-NTD) have been 
reported (6,7,13,24). These structures revealed a 
unique mode of binding of BTB-containing 
adaptor proteins to the C3RL family of E3 
ubiquitin ligases. Interaction with Cul3 is mainly 
via the BTB domain, with additional contacts 
from the 3-box region, while the BACK domain 
does not participate in the binding. The N-
terminal 22 residues of Cul3 (N-terminal 
extension, or NTE) is usually disordered and 
dispensable for binding, and many reported 
binding studies of BTB-domain containing 
proteins to Cul3 were carried out with N-
terminally truncated Cul3-NTD (Cul320-381 for 
KLHL3, SPOP and KCTD5, Cul323-388 for 
KLHL11 and Cul326-381 for KEAP1)(6,7,13,24). 
However, the Cul3-NTE does provide extra 
hydrophobic contacts with the 3-box region 
upon binding to KLHL11 and KCTD5, resulting 
in significant increases in affinity (6,25). 
Ubiquitin ligases act together with the 
proteasome to regulate the turnover of a large 
number of cellular proteins. Many viruses 
exploit the ubiquitylation-proteasomal 
degradation pathways to ensure successful 
infection and spread (35-41). To achieve this, 
viruses have evolved proteins that interact with 
ubiquitin ligase complex components to subvert 
the degradation pathways (35,37,39,42,43). 
The ectromelia virus (ECTV) orthologue of 
A55, EVM150, shares 93% sequence identity to 
A55. EVM150 has been reported to interact with 
Cul3 via its BTB domain and co-localizes with 
the C3RL and conjugated ubiquitin in cells (43). 
In addition, the BTB-domain of EVM150 was 
reported to inhibit NF-κB signalling, although 
Cul3 appeared dispensable for this activity (42). 
In this study, we showed that A55 binds 
directly to Cul3 and solved the crystal structure 
of a complex between Cul3-NTD and the BTB-
BACK (BB) domain of A55. While the overall 
conformation of the complex is similar to 
reported cellular BTB/Cul3-NTD structures, 
Cul3-NTD binds A55BB more tightly than it 
does cellular BTB proteins. This strong 
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A55/Cul3 interaction may allow VACV to 
redirect the E3 ubiquitin ligase complex to 
degrade novel target proteins and/or to subvert 
cellular BTB/Cul3-NTD interactions to rescue 
proteins from degradation.  
 
Results 
A55 binds to Cul3 of the E3 ubiquitin ligase 
complex via its N-terminal BB domain.  
Poxvirus BTB-Kelch protein EVM150 has 
been shown to co-precipitate with Cul3 and 
modulate innate immune responses upon 
infection (42,43). A55 is also predicted to have a 
BTB-Kelch domain architecture and shares 93% 
aa identity to EVM150. To test whether A55 
interacts with Cul3, co-immunoprecipitation 
experiments were performed using inducible 
HEK293T-REx cell lines expressing A55 with a 
FLAG-containing tandem affinity purification 
(TAP) tag at its N terminus (TAP-A55) or B14, 
an NF-κB inhibitor from VACV (44), with a C-
terminal TAP tag (B14-TAP). Endogenous Cul3 
co-immunoprecipitated with TAP-A55, but not 
B14-TAP, when overexpressed in HEK293T-
REx cells (Fig. 1A). This suggests that Cul3 
specifically co-immunoprecipitates with A55 
and not with other VACV immune modulatory 
proteins. Furthermore, TAP-A55 co-
immunoprecipitated with N-terminally myc-
tagged Cul3 (myc-Cul3) but not with myc-Cul5, 
suggesting that A55 interacts specifically with 
Cul3 and not with other cullin family proteins 
(Fig. 1B). To dissect the region of A55 that binds 
to Cul3, the BB and Kelch domains of A55 were 
tagged at the N terminus with TAP and were 
immunoprecipitated after overexpression in 
HEK293T-REx cells. Endogenous Cul3 co-
immunoprecipitated with the N-terminal BB 
domain, but not with the C-terminal Kelch 
domain (Fig. 1C). These results suggest that, like 
the ECTV BTB-Kelch protein EVM150, A55 
interacts with Cul3 and that this interaction is 
mediated solely by the N-terminal BB domain.  
 
A55 is an obligate dimer in solution and forms 
a 2:2 complex with Cul3. 
Previous biochemical and structural analysis 
has shown that Cul3 binds cellular BTB-Kelch 
proteins via its N terminus (residues 1-388) 
while its C terminus (389-767) is not required for 
binding (6-8,13). To test whether A55 forms a 
direct complex with Cul3 in solution, the A55 
BB domain (A55BB, residues 1-250) and the 
Cul3 N-terminal domain (Cul3NΔ22, residues 
23-388) were expressed in E. coli and purified 
according to protocols described in the 
experimental procedures. Size-exclusion 
chromatography coupled to multi-angle light 
scattering (SEC-MALS) studies together with 
SDS-PAGE analysis showed that A55BB exists 
as a homodimer in solution (expected molecular 
mass 60 kDa) (Fig. 1D). This is consistent with 
observations for other cellular BTB proteins (6-
8). Cul3NΔ22 is monomeric (expected 
molecular mass 46 kDa). However, when 
A55BB and Cul3NΔ22 were mixed at 
approximately 1:1 molar ratio, a complex was 
formed with an apparent molecular mass of 
141 kDa, consistent with a 2:2 complex of 
A55BB:Cul3N∆22 (expected molecular mass 
152 kDa) (Fig. 1, D and E). Overall, the results 
show that A55 is dimeric in solution and binds 
directly to Cul3 to form a heterotetramer.  
 
A55 binds to Cul3 with low- to sub-nanomolar 
affinity. 
Isothermal titration calorimetry (ITC) 
experiments were carried out to determine the 
binding affinity between A55BB and Cul3. Two 
different truncations of Cul3 containing the N-
terminal domain were used: Cul3N (residues 1-
388) and Cul3NΔ22 (residues 23-388) to 
compare the binding affinities between A55 and 
Cul3 with or without the Cul3-NTE. A55BB 
formed equimolar complexes with both 
Cul3NΔ22 and Cul3N with affinities in the low 
nanomolar (5.3 ± 2.9 nM) and sub-nanomolar 
(< 1 nM) range, respectively (Fig. 2, A and B; 
Table 1). The binding affinity of A55BB for 
Cul3N could not be determined accurately as 
rapid depletion of free Cul3N in the cell upon the 
introduction of A55BB prevented fitting of the 
resultant titration data to a single-site binding 
model. Attempts to lower the concentrations of 
A55BB and Cul3N or to use displacement 
titration experiments (45) were unsuccessful due 
to limitations of instrument sensitivity. Previous 
studies have shown cellular BTB proteins to bind 
the Cul3 N-terminal domain with much lower 
affinities than observed for A55BB (6-8,13). To 
facilitate a direct comparison, the binding of 
KLHL3-BB to Cul3N and Cul3NΔ22 was 
measured by ITC (Fig. 2, C and D). These 
experiments confirmed that the affinity of Cul3-
NTD for A55BB is approximately ten-fold 
tighter than for KLHL3-BB (Fig. 2, C and D; 
Table 1). Interestingly, the affinity of A55BB for 
Cul3NΔ22 was stronger despite the enthalpic 
contribution to the interaction (ΔH = -9.9 ± 0.8 
kcal/mol) being lower than for the equivalent 
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interaction between KLHL3-BB and Cul3NΔ22 
(ΔH = -18.9 ± 1.3 kcal/mol) (Table 1). This 
suggests that the tighter interaction arises from a 
more favourable entropic contribution upon 
complex formation, such as the burial of exposed 
hydrophobic regions leading to the release of 
ordered solvent molecules and/or less 
conformational restriction of A55 upon complex 
formation. Taken together, the ITC data 
presented here show that the VACV A55BB 
binds Cul3-NTD more tightly than previously-
studied cellular BTB domain-containing 
proteins (Table 1) and that different 
thermodynamic properties of the interaction 
contribute to this enhanced binding. 
 
Determination of the A55BB/Cul3NΔ22 
complex structure.  
To understand the molecular mechanism 
underlying the observed high-affinity interaction 
between A55BB and Cul3-NTD, the 
A55BB/Cul3NΔ22 complex was purified and 
subjected to extensive crystallization screening 
for structural characterization. Initial trials did 
not yield any crystals. To promote crystallization, 
A55BB was subjected to surface entropy 
reduction by reductive methylation (46) before 
being purified in complex with Cul3NΔ22 (Fig. 
S1). Crystals of methylated (M) A55BB in 
complex with Cul3NΔ22 grew as thin needles 
after two weeks. By using microseeding and 
varying the pH and concentration of the 
precipitants, optimized crystals were grown that 
diffracted to 2.3 Å in the best direction. 
Inspection of the diffraction data suggested 
severe anisotropy, with significantly worse 
diffraction along one axis (3.7 Å in direction 
0.76 a* - 0.65 c*) compared to the other major 
axes (2.6 Å in the direction b* and 2.3 Å in the 
direction 0.92 a* + 0.39 c*), so these data were 
processed with anisotropic scaling and 
truncation using STARANISO (47) and DIALS 
(48). The final processed dataset contained 
23,509 unique reflections (Table 2), equivalent 
to the number of reflections expected for a 2.8 Å 
dataset collected from an isotropically-
diffracting crystal with equivalent space group 
and unit cell dimensions. The anisotropy of 
diffraction was present in all crystals of the 
A55BB(M)/Cul3NΔ22 complex for which data 
were collected (>20 individual crystals). 
The structure of A55BB(M)/Cul3NΔ22 
crystal was solved by molecular replacement 
using B-cell lymphoma 6 BTB domain (PDB 
code 1R29) (49) and Cul320-381 from the 
SPOP/Cul3 complex structure (PDB code 4EOZ) 
(13) as the search models. While most of the 
Cul3NΔ22 molecule could be modelled with 
ease, the initial map for A55BB was less well-
defined with relatively weak density for the 
3-box and BACK regions. Anisotropic scaling of 
the diffraction data and the use of interactive 
molecular dynamics in ISOLDE (50) improved 
the model quality and fit to density significantly. 
The final model was refined using BUSTER (51) 
and has residuals Rwork/Rfree of 0.266/0.282 with 
good overall geometry. Data collection and 
refinement statistics are summarized in Table 2. 
No crystals of A55BB(M) either alone or in 
complex with Cul3N could be obtained despite 
extensive crystallization trials. 
 
Structurally A55BB resembles cellular BTB-
Kelch proteins with conserved Cul3-binding 
and dimerization interfaces.  
The structure of the A55BB(M)/Cul3NΔ22 
complex contains one copy of each molecule in 
the crystallographic asymmetric unit (Fig. 3A). 
Consistent with the SEC-MALS analysis, a 
heterotetramer of A55BB(M)/Cul3NΔ22 can be 
observed by applying crystallographic 2-fold 
symmetry. A55BB dimerization is mediated by 
the BTB domain, where the N-terminal helix (α1) 
forms a domain-swapped interaction with the 
symmetry-related molecule (Fig. 3B). The 
Cul3NΔ22 molecule is all-helical and closely 
resembles previously solved Cul3 N-terminal 
domain structures, with root-mean-squared 
displacement of 0.8 Å and 0.7 Å across 336 and 
339 Cα atoms when aligned to the Cul3 
structures in the KLHL3/Cul3NΔ19 (7) and 
KLHL11/Cul3NΔ22 (6) complexes, 
respectively (Fig. 3C). A55BB consists of a 
globular BTB domain (residues 1-118; helices 
α1-α6 and strands β2-β4) followed by a helix-
turn-helix 3-box region (residues 119-149; 
helices α7-α8) and an all-helical BACK domain 
(residues 150-196, helices α9-α12) (Fig. 3A). 
A55BB closely resembles the equivalent regions 
of KLHL3 and KLHL11 (root-mean-squared 
displacements of 2.2 Å and 2.5 Å across 167 and 
181 Cα atoms, respectively), despite the low 
sequence conservation between A55 and these 
cellular proteins (Fig. S2 and Fig. 4), and the 
formation of dimers via an N-terminal helix 
domain swap is a conserved feature of all three 
proteins (Fig. 3D). 
Overall, the A55BB/Cul3NΔ22 complex 
closely resembles other structures of Cul3 in 
complex with cellular BTB-domain containing 
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proteins (Fig. 3C). The A55-binding interface of 
Cul3-NTD is formed primarily of residues in 
helices α2 and α5, with extra contacts from the 
α1-α2 loop and from the C terminus of α3. 
Residues at the Cul3-binding interface of 
A55BB are primarily found in the BTB domain 
with additional contacts in the 3-box region; the 
BACK domain does not contribute to the 
interaction (Fig. 4). This mode of interaction is 
consistent with the KLHL3/Cul3 (7), 
KLHL11/Cul3 (6) and KEAP1/Cul3 (PDB code 
5NLB) complex structures (Fig. S2). Analyses 
of the interface areas and the number of interface 
residues for A55 and all available BTB/Cul3 
complex structures showed no striking overall 
differences (Fig. S2). However, compared to 
other BTB/Cul3-NTD structures the 
A55BB/Cul3 interface has more hydrogen bonds 
and a reduced contribution from hydrophobic 
interactions (Fig. S2). 
Only 196 of the 250 aa residues that comprise 
A55BB could be modelled confidently: the 
density for side chains in the last modelled helix 
of the BACK domain (α10, residues 180-196) is 
weak compared with density for side chains at 
the BTB/Cul3 interface (Fig. S3, A and B), and 
density for BACK domain residues 197-250 was 
not sufficiently well resolved to be modelled 
unambiguously (Fig. S3C). Correspondingly, 
the B factors of A55 residues at the Cul3-binding 
interface are lower than in the BACK domain 
(Fig. S3D). Inspection of the crystal lattice 
shows large solvent channels next to the BACK 
domain and this lack of crystal contacts at the C 
terminus is likely to account for the poor density 
observed in this region (Fig. S3, C and E). When 
superimposing KLHL11 and KLHL3 onto 
different regions of A55, inter-domain flexibility 
is evident (Fig. S4, A to D and E to F, 
respectively). Two pivot points in the structure 
can be found: the BTBα5-α6 helix-turn-helix and 
the 3-box region, respectively; the latter appears 
to be the major pivot point around which the 
BTB and BACK domain rotate relative to each 
other (Fig. S4, I to K). When measuring the 
angles between different subdomains (BTBα1-4, 
BTBα5-α6, 3-box and BACK), the angle formed 
by BTBα5-α6 -3-box-BACK in A55 is much larger 
compared to the corresponding angles in KLHL3 
and KLHL11, thus rendering A55 more linear 
across the BB domain than KLHL3 and 
KLHL11 (Fig. S4, I to K). 
Crystals of the A55BB/Cul3NΔ22 could be 
obtained only when the A55BB protein had been 
methylated in vitro. While there was density 
consistent with the presence of additional atoms 
adjacent to the amino termini of two lysine side 
chains (K36 and K132), they were not 
sufficiently well resolved to allow modelling of 
the methyl groups (Fig. S5A). Only one lysine 
(K136) was found at the binding interface (Fig. 
S5B) and ITC studies showed that methylated 
A55BB binds to Cul3 with affinity similar to 
unmodified A55BB (Fig. S5, C and D).   
 
A hydrophobic interaction at A55 residue 48 is 
required for high-affinity binding to Cul3.  
Despite similarity in the overall structures, 
A55BB binds Cul3-NTD with much higher 
affinity than other BTB proteins. It has been 
suggested the key determinant for the interaction 
with Cul3 is a conserved ϕ-X-D/E motif found in 
the α3-β4 loops of the BTB domain, where ϕ is 
a hydrophobic residue and X is any residue 
(6,7,13). This motif exists in A55, corresponding 
to residues F54 (ϕ), I55 (X) and D56 (D/E), 
respectively (Fig. 4 and Fig. 5B). As in KLHL3, 
KLHL11 and SPOP, the side chain of residue ϕ 
(F54) in A55 is buried in a hydrophobic cavity 
on the surface of Cul3 (Fig. 5, C to F). Mutation 
of the ϕ residue in SPOP to a charged residue 
(M233E) completely abolished binding to Cul3, 
highlighting the significance of the ϕ residue for 
the interaction (13). An F54E mutant of A55BB 
was purified and shown to have similar thermal 
stability to the wild-type protein (Fig. 6, A and 
B). ITC analysis demonstrated that the F54E 
mutation reduces the affinity of A55BB for 
Cul3NΔ22 and Cul3N by at least 10-fold 
compared to the wild-type protein, yielding 
dissociation constants (KD) similar to those of 
cellular BTB proteins (Fig. 6, C and D; Table 3). 
This suggests that ϕ residue F54 of A55 is 
involved in the interaction but not critical for 
binding to Cul3. A55 residue D56, equivalent to 
the D/E residue of the ϕ-X-D/E motif, forms side 
chain and backbone hydrogen bonds with Cul3 
residues S53 and F54, respectively. A D56A 
mutation was introduced into A55 but the mutant 
could not be purified following bacterial 
expression, suggesting D56 is critical for the 
correct folding of A55.  
As the ϕ-X-D/E motif was not absolutely 
required for binding of A55 to Cul3, the 
contribution of other residues was investigated. 
A hydrogen bond is formed between D99 of A55 
and Y125 of Cul3 and this interaction is 
conserved in KLHL11 and SPOP but not in 
KLHL3 (Fig. 5G). Mutation at this site only 
caused moderate reduction in affinities for both 
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Cul3NΔ22 and Cul3N (Fig. 6, E and F). Residue 
I48 of A55 is adjacent to the ϕ residue F54 and, 
like F54, the side chain of I48 extends into a 
hydrophobic cleft on the Cul3 surface (Fig. 5C). 
This residue is not conserved in KLHL3, 
KLHL11 or SPOP and the equivalent residues 
(A77, P124 and A227, respectively) have 
smaller side chains and form less extensive 
interactions (Fig. 5, D to F). Two mutant forms 
of A55BB were generated, A55BB-I48E and 
A55BB-I48A, and both were shown to have 
similar thermal stability to the wild type protein 
(Fig. 6, A and B). A55BB-I48A retained high 
affinity for Cul3NΔ22 and Cul3N (Fig. 6, G and 
H). However, the I48E substitution reduced 
Cul3NΔ22 binding to levels undetectable by ITC 
and reduced the affinity for Cul3N by at least 
two orders of magnitude (Fig. 6, I and J), to well-
below those of the cellular BTB proteins for 
Cul3-NTD (Table 1 & 3). The residual binding 
of A55BB-I48E to Cul3N is likely to be 
mediated via contacts with Cul3N-NTE, as has 
been characterized previously for KLHL11 (6). 
 
Discussion  
An interaction between a poxvirus BTB-
Kelch protein and Cul3 has been demonstrated 
previously for the ECTV protein EVM150 by 
co-immunoprecipitation from transfected cells 
(42,43). Cellular BTB proteins have been 
reported to bind directly to Cul3 (6-
8,13,24,25,33). However, due to low sequence 
identity (20–25%) between poxvirus and cellular 
BTB proteins (Fig. 4), it was unclear whether 
EVM150 and other poxvirus BTB-Kelch 
proteins would bind Cul3 in a similar manner. 
Here, we show that VACV BTB-Kelch protein 
A55, a close orthologue of EVM150, also binds 
to Cul3, and this interaction is direct in nature. 
Surprisingly, the binding of Cul3 to A55BB is 
much tighter than to human BTB domains (Fig.2, 
Table 1). To understand the molecular basis of 
this tight interaction the crystal structure of the 
A55BB/Cul3NΔ22 complex was determined 
using anisotropic diffraction data extending to 
2.3 Å (with an observation:parameter ratio 
equivalent to that of an isotropic 2.8 Å resolution 
structure). This is the first reported crystal 
structure of a virus BTB-Kelch protein in 
complex with the E3 ubiquitin ligase scaffold 
protein Cul3. 
The overall conformation of the 
A55BB/Cul3-NTD complex resembles closely 
the structures of other cellular BTB/Cul3-NTD 
protein complexes, with similar mode of 
dimerization and conserved Cul3-binding 
interface despite low sequence identities (Fig. 3, 
C to E; Fig. S2). The interface area and the 
number of interface residues at the 
A55BB/Cul3NΔ22 binding interface are 
comparable to cellular BTB/Cul3-NTD 
interfaces (Fig. S2, inset table). The conserved 
ϕ-X-D/E motif, which was found to be a key 
contributor to the interaction between SPOP and 
Cul3, is conserved in A55 (Fig. 4 and Fig. 5B) 
(13). However, mutation of F54 to glutamate at 
the ϕ position in A55BB only moderately 
reduced its affinity for Cul3 (Fig. 6, C and D), 
whereas the equivalent mutation in SPOP 
resulted in complete loss of binding (13). A55 
residue I48, adjacent to F54, makes more 
extensive contacts with Cul3 than the equivalent 
residues in cellular BTB proteins (Fig. 5, C to F). 
Substitution of I48 to alanine caused only a 
modest decrease in affinity (Table 3), 
demonstrating that the additional hydrophobic 
interactions mediated by isoleucine at this 
position are not the sole determinant of higher-
affinity Cul3 binding by A55BB. However, 
substitution of I48 to glutamate weakened the 
interaction with Cul3 N-terminal domain lacking 
the NTE (Cul3NΔ22) such that to it could no 
longer be detected by ITC, and reduced the 
affinity for the full Cul3 N-terminal domain 
(Cul3N) by at least two orders of magnitude (Fig. 
6, G and H; Table 3). An equivalent mutation 
(A77E) in KLHL3 similarly reduced the affinity 
for Cul3NΔ20 to levels undetectable by ITC (7). 
Taken together, these results confirm that 
hydrophobic interactions at this position, 
adjacent to the conserved ϕ-X-D/E motif, are 
necessary for binding of BTB proteins to Cul3. 
Interestingly, ITC studies suggest that the 
A55BB/Cul3-NTD interaction is more 
entropically favourable than the KLHL3-
BB/Cul3-NTD interaction (Fig. 2 and Table 1), 
whereas structural analysis suggests that 
hydrophobic interactions contribute less energy 
(via the entropically-favourable release of 
solvent) to the A55/Cul3 interaction (Fig. S2, 
inset table). In Cul3-bound KLHL3, KLHL11 
and SPOP structures the α3-β4 loops, which 
contain the ϕ residue and interact with 
hydrophobic pockets on the Cul3 surface, adopt 
helical conformations (helix α3.1, Fig. 5, B, D to 
F). In A55, the ϕ residue F54 also fits into a deep 
hydrophobic pocket on the surface of Cul3 but 
the α3-β4 loop of A55 does not adopt a helical 
conformation (Fig. 5, A and C). Interestingly, in 
the structures of unbound KLHL11 and SPOP 
Structure of Cul3 in complex with vaccinia virus protein A55 
 
7 
 
the α3-β4 loop containing the ϕ residue is less 
well ordered and has a different conformation 
(6,8). Such structural rearrangement upon 
binding to Cul3 would present an entropic 
penalty to binding. It is tempting to speculate 
that a lack of such α3-β4 loop rearrangement, 
rather than the burial of exposed hydrophobic 
regions, contributes to the entropically-
favourable tight binding of A55BB to Cul3-NTD. 
Further, such structural rearrangement may not 
occur in the absence of the favourable 
hydrophobic interaction mediated by the ϕ 
residue, suggesting a mechanism by which 
binding to Cul3 would be more significantly 
diminished for SPOP than for A55 when this 
residue was mutated. 
Sequence alignments reveal the BB domains 
of A55 and other orthopoxvirus BTB-Kelch 
orthologues such as EVM150 to share extensive 
(>77%) identity (Table 4), including 
conservation of the residues in the ϕ-X-D/E 
motif and I48 (Fig. 7). This strongly suggests 
that the interaction between A55 orthologues 
and Cul3 is conserved amongst poxviruses. In 
contrast, most of the Cul3-binding residues of 
A55 are not conserved in the other two VACV 
BTB-Kelch proteins, C2 and F3 (Fig. 7), which 
share little sequence identity to A55 (25% and 
23%, respectively). This suggests that these 
proteins are unlikely to interact with Cul3, 
despite being classified as BTB-Kelch proteins, 
and is consistent with these proteins being 
functionally distinct (4,31,32). The N-terminal 
dimerization helix of the BTB domain appears to 
be missing in C2 (Fig. 7) suggesting that, unlike 
most BTB-Kelch proteins, C2 may not be able to 
form homo- or hetero-dimers via the same 
mechanism as A55. 
In vivo, VACV expressing A55 induced a 
smaller lesion in murine model of intradermal 
infection compared to a virus lacking A55 (4). In 
cells, the BTB domain of the ECTV EVM150 
was reported to inhibit TNFα-induced NF-κB 
activation; however, this inhibition appears to be 
Cul3 independent (42). The interaction between 
A55 and Cul3 therefore is unlikely to be relevant 
for the inhibition of NF-κB signalling. As a 
scaffold protein for an E3 ubiquitin ligase 
complex, Cul3 not only interacts with the BTB-
Kelch family of adaptor proteins but also other 
BTB-domain containing adaptor proteins such as 
BTB zinc-finger proteins, MATH-BTB proteins, 
small RhoBTB GTPases and potassium channel 
tetramerization domain (KCTD) proteins 
(5,8,10,13,20,24,52). The outcome of the 
interaction will depend on the specific substrates 
recruited by the BTB adaptor proteins and will 
regulate a diverse range of cellular processes, 
including hypoxic response, ion-channel gating, 
as well as cytoskeleton organization (19,53,54). 
The fact that A55BB is able to bind Cul3-NTD 
with much stronger affinity than reported 
cellular binding partners suggest two possible 
functions of A55. First, A55 may bind to Cul3 
and redirect the E3 ubiquitin ligase complex to 
ubiquitylate otherwise untargeted proteins for 
proteasomal degradation. Alternatively, A55 
may sequester Cul3 and prevent the 
ubiquitylation and/or proteasomal degradation 
of proteins that are normally 
ubiquitylated/degraded upon viral infection. 
Further experiments are required to discriminate 
whether A55 fulfils either or both of these roles 
during infection. 
A55BB binding to the Cul3 N-terminal 
domain is significantly increased by the presence 
of the N-terminal 22 amino acids of Cul3 (Table 
1), and the I48E mutant lacks the ability to bind 
Cu3NΔ22 yet can bind Cul3N with nanomolar 
affinity (Table 3). This N-terminal extension 
(NTE) of Cul3 has been shown to interact 
extensively with a hydrophobic groove formed 
primarily by the 3-box region of KLHL11 (Fig. 
S6A) (6). Comparison of the structures of 
KLHL11 in complex with Cul3N or Cul3NΔ22 
shows this groove to be pre-formed, rather than 
being induced by NTE binding (Fig. S6, A and 
B). However, sequence and structural alignment 
of A55 and KLHL11 suggest that an equivalent 
hydrophobic groove is not present on the surface 
of A55 (Fig. 4 and Fig. S6C). Indeed, the BTB, 
3-box and BACK domains are arranged in linear 
fashion in A55 whereas they form a crescent in 
KLHL11 or KLHL3 (Fig. S4, I to K). It is 
therefore likely that A55 binds the Cul3-NTE via 
a different set of interactions. Crystallization 
trials of A55 with Cul3 containing the NTE 
region (Cul3N) have to date been unsuccessful, 
and further studies are thus needed to identify 
residues key for the interaction between A55 and 
the Cul3-NTE.  
 
Conclusion  
The structure of the first virus BTB-Kelch 
protein in complex with Cul3 is presented here, 
which has provided insight into how poxviruses 
may utilize the host Cul3-based E3 ubiquitin 
ligase complex for its own benefit. A55 binds 
Cul3 with much stronger affinity than cellular 
BTB-Kelch proteins. A single point mutation in 
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A55, I48E, significantly diminishes Cul3 
binding and could be exploited by future studies 
to probe the contribution of the A55/Cul3 
interaction to VACV virulence. 
 
Experimental Procedures 
Construct design  
Codon optimized vaccinia virus (VACV) 
strain Western Reserve (WR) gene A55R 
(Uniprot P24768) full length, A55R BTB 
(residues 1-250) and A55R Kelch (residues 251-
565), or VACV WR B14R (Uniprot P24772) 
were subcloned into pCDNA4/TO for inducible 
expression in mammalian cells with an N or C-
terminal STREPI and STREPII tag followed by 
FLAG tag (TAP), respectively. The mammalian 
expression vectors pcDNA-myc-CUL3 (19893) 
and pcDNA-myc-CUL5 (19895) were purchased 
from Addgene. The sequence encoding A55 BB 
domain of the VACV strain WR (residues 1-250) 
was codon-optimized for expression in 
mammalian cells and cloned into the pOPTnH 
vector (55) for expression in E. coli with a C-
terminal Lys-His6 tag. Human Cul3NΔ22 
(Uniprot Q13618, residues 23-388) and Cul3N 
(Uniprot Q13618, residues 1-388) with the 
I342R and L346D stabilizing mutations (6) in 
pNIC-CTHF with C-terminal TEV-cleavable 
His6-tags were a gift from Nicola Burgess-
Brown (Addgene plasmids 53672 and 53673). 
KLHL3 (Uniprot Q9UH77, residues 24-276) 
cloned into pMCSG7 with an N-terminal TEV-
cleavable His6-tag was a gift from Alan X. Ji and 
Gilbert G. Prive (7). Quick-change mutagenesis 
PCR (Agilent) was used to generate the A55-
F54E, A55-D56A, A55-D99A, A55-I48A and 
A55-I48E mutants as per the manufacturer’s 
protocol. 
 
Immunoprecipitation 
HEK293T-REx (Invitrogen) cells were 
maintained in Dulbecco’s modified minimal 
essential medium (DMEM; Gibco) 
supplemented with 10% foetal bovine serum 
(FBS; Pan Biotech), non-essential amino acids 
(NEAA; Gibco) and 50 μg/ml 
penicillin/streptomycin (Gibco) at 37 °C in a 5% 
CO2 atmosphere. HEK293T-REx inducible cell 
lines were constructed following transfection 
with the pCDNA4/TO expression plasmids 
described above using LT1 transfection reagent 
following the manufacturer’s instructions 
(MirusBio). Transfected cells were selected and 
maintained in DMEM supplemented with 10 
μg/ml blasticidin and 100 μg/ml zeocin, 
following the manufacturer’s instructions 
(Invitrogen). B14-TAP, TAP-A55, TAP-A55-
BTB (TAP-A55BB) or TAP-A55-Kelch 
HEK293T-REx cells were induced for 24 h with 
2 µg/ml doxycycline, washed in ice-cold 
phosphate-buffered saline (PBS) and 
subsequently were lysed in either 0.5% NP40 
(IGEPAL CA-630) in PBS supplemented with 
protease inhibitor or RIPA buffer (50 mM Tris 
pH 8.0, 1% NP40, 150 mM NaCl, 0.5% sodium 
deoxycholate, 0.5 mM EDTA, 0.1% SDS 
supplemented with protease inhibitor) where 
stated. Lysates were cleared at 15,000 g at 4 °C 
and proteins were immunoprecipitated at 4 °C 
overnight with FLAG M2 beads or Fastflow G-
Sepharose (GE Healthcare) incubated previously 
with mouse monoclonal anti-myc clone 9B11 
(CST; #2276) at 1:50 dilution. Beads were 
washed 3 times in 1 mL lysis buffer by 
centrifugation for 1 min at 8,000 g. After the 
final wash, beads were incubated in 4× sample 
loading dye (0.5 M Tris pH 6.8, 40% glycerol, 6% 
SDS, 1% bromophenol blue and 0.8% β-
mercaptoethanol), boiled and analysed by 
immunoblotting. 
 
Protein expression and purification  
Wild-type and mutant A55BB and Cul3NΔ22 
were expressed in B834(DE3) E. coli cells 
(Novagen), while Cul3N and KLHL3 were 
expressed in Rosetta2(DE3)pLysS E. coli cells 
(Novagen). Bacteria were grown at 37 °C in 
2× TY medium with shaking at 200 rpm to an 
OD600 of 0.7-0.9, whereupon protein 
expression was induced by either adding 0.2 mM 
IPTG and incubating at 37 °C for 4 h (Cul3N) or 
by cooling the cultures to 22 °C, adding 0.2 mM 
IPTG and incubating for 4 h (Cul3NΔ22) or 
overnight (wild-type and mutant A55). Cells 
were harvested by centrifugation at 5,000 g for 
15 min and pellets were stored at -80 °C.  
Cells were thawed and resuspended in lysis 
buffer containing 20 mM HEPES pH 7.5, 500 
mM NaCl, 1 mM β-mercatoethanol, 0.05% 
Tween-20, 0.5 mM MgCl2, 400 U bovine DNase 
I (Roche) and 200 µL EDTA-free protease 
inhibitor mixture (Sigma-Aldrich). Cells were 
lysed by passage through a TS series cell 
disruptor (Constant Systems) at 24 kpsi. Lysates 
were collected and cleared by centrifugation at 
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40,000 g for 30 min at 4 °C. Cleared lysates were 
applied to a 5 mL HiTrap TALON crude column 
(GE Healthcare) pre-equilibrated with binding 
buffer (20 mM HEPES pH 7.5, 500 mM NaCl, 5 
mM β-mercaptoethanol) to capture the His6-
tagged proteins. The column was washed with 
binding buffer and the bound proteins were 
eluted with a gradient of 10-150 mM imidazole 
in binding buffer. Eluted proteins were pooled, 
concentrated and further purified by SEC using 
a Superdex 200 column (GE Healthcare) 
equilibrated in gel filtration buffer (20 mM 
HEPES pH 7.5, 200 mM NaCl, 1 mM DTT). For 
Cul3N, an additional anion-exchange 
chromatography purification step was performed 
by exchanging the protein into 20 mM Tris pH 
7.5, 10 mM NaCl, 1 mM DTT and applying to a 
MonoQ 5/50 GL column (GE Healthcare) before 
eluting with a linear gradient of NaCl (10 mM to 
1M). Purified proteins were concentrated, snap 
frozen in liquid nitrogen and stored at -80 °C. 
A55BB migrates more rapidly than expected in 
SDS-PAGE: peptide mass fingerprinting was 
used to confirm the identity and integrity of the 
purified protein. 
 
Size-exclusion chromatography coupled to 
multi-angle light scattering (SEC-MALS)  
SEC-MALS experiments were performed at 
room temperature. For each experiment, 100 µL 
protein at 3 mg/mL was injected onto a Superdex 
200 increase 10/300 GL column (GE Healthcare) 
pre-equilibrated with 20 mM HEPES, 150 mM 
NaCl and 2 mM DTT at a flow rate of 0.5 
mL/min. The static light scattering, differential 
refractive index and the UV absorbance at 280 
nm were measured in-line by DAWN 8+ (Wyatt 
Technology), Optilab T-rEX (Wyatt Technology) 
and Agilent 1260 UV (Agilent Technologies) 
detectors. The corresponding molar mass from 
each elution peak was calculated using ASTRA 
6 software (Wyatt Technology).  
 
Isothermal titration calorimetry (ITC) 
ITC experiments were carried out at 25 °C on 
an automated MicroCal PEAQ-ITC (Malvern 
Panalytical). Proteins were exchanged into gel 
filtration buffer (20 mM HEPES, 200 mM NaCl, 
1 mM DTT) either by SEC or extensive dialysis 
prior to experiments. Titrants (wild-type and 
mutant A55 and KLHL3) at concentrations 
between 70 and 100 µM were titrated into 7 µM 
of titrates (Cul3NΔ22 or Cul3N) either as 19 × 
2 μL injections (wild-type A55, I48E mutant and 
KLHL3) or 13 × 3 μL injections (mutant A55 
except I48E). Data were analyzed using the 
MicroCal PEAQ-ITC analysis software 
(Malvern Panalytical) and fitted using a one-site 
binding model.   
 
Reductive methylation  
Reductive methylation was carried out at 4 °C 
using modified protocols from Walter et al. (46). 
Purified A55BB was diluted to 0.8 mg/mL and 
dialyzed into buffer containing 50 mM HEPES 
pH 7.5 and 250 mM NaCl. The protein was 
mixed with 20 µL/mL of 1 M dimethylamine-
borane complex (Sigma) and 40 µL/mL of 1% 
formaldehyde (UltraPure EM grade, 
Polysciences) and incubated for 2 hrs at 4 °C. 
This step was repeated once before mixing with 
an additional 10 µL/mL of 1 M dimethylamine-
borane complex and incubating overnight at 4 °C. 
The reaction was quenched with 10 µL of 1 M 
Tris pH 7.5. Methylated A55BB was further 
purified by SEC using a Superdex 200 10/300 
GL column equilibrated in 20 mM Tris pH 7.5, 
200 mM NaCl and 1 mM DTT before being 
concentrated, snap-frozen and stored at -80 °C. 
 
Isoelectric focusing (IEF) gel analysis  
The IEF gel analysis was performed at 4 °C 
using a Novex pH 3 to 7 IEF gel (ThermoFisher 
Scientific) according to manufacturer’s 
instructions. Native and methylated A55BB 
were diluted with MilliQ water to 0.8 mg/mL in 
a total volume of 5 µL and mixed with an equal 
volume of 2× Novex pH 3 to 10 IEF sample 
buffer (ThermoFisher) before loading onto the 
IEF gel. The gel was fixed in 12% TCA for 30 
min and washed with MilliQ water before 
staining with InstantBlue Protein Stain 
(Expedeon). 
 
Differential Scanning Fluorimetry (DSF)  
DSF experiments were performed in 96-well 
PCR microplates (Axygen Scientific) on a 
ViiA 7 Real-Time PCR machine (Life 
Technologies). To each well of the plate, buffer 
(20 mM HEPES, 200 mM NaCl, 1 mM DTT), 
protein and 10× protein thermal shift dye 
(Applied Biosystems) were mixed at 8:1:1 
volume ratio in a final volume of 20 µL and a 
protein concentration of 0.2 µg/µL. Samples 
were subjected to thermal denaturation from 
25 °C to 95 °C with 1 °C increment per 20 s and 
real-time fluorescence was recorded. 
Normalized melt curves were fitted to a biphasic 
sigmoidal curve using Prism7 (GraphPad 
Structure of Cul3 in complex with vaccinia virus protein A55 
 
10 
 
Software) and the melting temperatures (Tm) 
were taken as mid-points of the sigmoids.  
 
Crystallization and data collection  
Methylated A55BB was mixed with 
Cul3NΔ22 at 1:1 molar ratio and the complex 
was purified by SEC using a Superdex 200 
10/300 GL column (GE Healthcare) in 20 mM 
Tris pH 7.5, 200 mM NaCl, 1 mM DTT. The 
purified complex was concentrated to 16.3 
mg/mL and sitting-drop vapour diffusion 
experiments were attempted by mixing 100 nL 
protein with 100 nL reservoir (4% (v/v) 
tacsimate pH 6.5, 12% (w/v) PEG3350) and 
equilibrating against 80 µL of the reservoir 
solution at 20 °C. Thin needles were observed 
after two weeks. Varying the pH, concentration 
of the tacsimate, concentration of PEG3350 and 
the protein:reservoir ratio in the sitting drops 
gave rise to larger crystals that diffracted to 
~3.8 Å on Diamond beamline I03. For further 
optimization, seed stocks for microseeding were 
generated as described previously (56). Briefly, 
crystals were crushed and transferred into 50 µL 
of stabilizing solution (original reservoir 
solution), vortexed, and seven five-fold serial 
dilutions of seed into stabilizing solution were 
generated. Sitting drops were prepared using 
100 nL of protein, 150 nL of reservoir and 50 nL 
of seed stock. Eventually, a drop containing 3.29% 
(v/v) tacsimate pH 6.5, 9.92% (w/v) PEG3350 
and 50 nL of 625-fold diluted seed stock gave 
rise to crystals that diffracted to 2.3 Å in the best 
direction on Diamond beamline I04. The crystals 
were cryoprotected by briefly sweeping through 
reservoir solution containing 25% (v/v) glycerol 
and flash-cryocooled by plunging into liquid 
nitrogen. Diffraction data were collected at 100K 
on the Diamond beamline I04. Data were 
indexed and integrated using DIALS (57) as 
implemented by the xia2 processing pipeline 
(58). Due to severe anisotropic diffraction, 
diffraction data were subject to anisotropic 
scaling using STARANISO (47) and AIMLESS 
(59). 
 
Structure determination 
The structure of A55BB(M)/Cul3NΔ22 
complex was solved by molecular replacement 
using PHENIX PHASER-MR (60). An initial 
search using each domain of the SPOP/Cul3 
complex (13) (PDB code 4EOZ) as search 
models successfully placed one copy of 
Cul3NΔ22, but no solution corresponding to 
A55BB was forthcoming. MOLREP (61) from 
the CCP4 program suite (62) was used to locate 
the A55 BTB domain using B-Cell Lymphoma 6 
BTB Domain (49) (PDB code 1R29) as a search 
model. The 3-box region and the first four 
helices of the A55 BACK domain (α9-α12) were 
manually built using COOT (63) with iterative 
rounds of refinement using Refmac5 (64). The 
structure was improved by the use of real time 
molecular dynamics assisted model building and 
map fitting with the program ISOLDE (50), 
followed by TLS and positional refinement 
using BUSTER (51). The quality of the model 
was monitored throughout the refinement 
process using Molprobity (65).  
 
Bioinformatics and structural analysis  
Multiple sequence alignments were 
performed using Clustal Omega (66) and 
annotated using ALINE (67). Analyses of the 
binding interfaces were performed using the 
PDBePISA webserver (68). Molecular figures 
were generated using PyMOL (69). 
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The abbreviations used are: BACK, BTB and C-terminal Kelch; BTB, Bric-a-brac, Tramtrack and 
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type POZ protein; TAP, tandem affinity purification tag; TRAF, tumour necrosis factor receptor 
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Table 1. Comparison of the dissociation constants (KD), enthalpic change (ΔH) and entropic 
change (TΔS) for BB/Cul3 interaction. Experiments for this study were performed at least twice and 
mean ± SEM is shown. 
BTB+, BTB domain + 3-box region. *Not defined since KD could not be accurately measured. **Value 
as reported in Zhuang et al., 2009(8). ***Value as reported in Errington et al., 2012(13). ****Values 
as reported in Canning et al., 2013(6).  
  
 Cul3NΔ22 Cul3N 
Protein KD 
(nM) 
ΔH 
(kcal/mol) 
TΔS 
(kcal/mol) 
KD 
(nM) 
ΔH 
(kcal/mol) 
TΔS 
(kcal/mol) 
A55 5.3 ± 2.9 -9.9 ± 0.8 -1.8 ± 0.8 < 1 -17.7 ± .1.1 -* 
KLHL3 52.8 ± 16.6 -18.9 ± 2.0 9.0 ± 2.3 17.0 ± 5.1 -24.9 ± 0.9 14.2 ± 0.7 
SPOPBTB+ - - - 17** - - 
SPOP 13 ± 2*** - - - - - 
KLHL11 650**** - - 20**** - - 
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Table 2.  A55BB Cul3NΔ22 complex data collection and refinement statistics. Statistics for data 
from a single crystal before (Isotropic) and after anisotropic truncation and scaling using STARANISO 
(Anisotropic) are shown. Statistics for the highest-resolution shell are shown in parentheses. 
Data collection   
Beamline Diamond I04 
Wavelength 0.9795 Å 
Space group C 1 2 1 
Cell dimensions   
a, b, c (Å) 198.8, 42.5, 148.8 
β (degrees) 128.4 
Scaling procedure Isotropic Anisotropic 
Resolution range (Å) 99.2–2.3 (2.36–2.30) 116.6–2.3 (2.51–2.30) 
Total reflections 568,838 (41,470) 300,453 (14,478) 
Unique reflections 44,144 (3279) 23,509 (1172) 
Multiplicity 12.9 (12.6) 12.8 (12.4) 
Completeness (%) 100 (99.9) 53.2 (11.6) 
Mean( I/σ(I) ) 8.1 (0.1) 15.3 (2.2) 
Rpim 0.040 (4.996) 0.025 (0.295) 
Rmerge 0.140 (17.224) 0.087 (1.005) 
CC½ 0.999 (0.302) 1.000 (0.848) 
Refinement   
Resolution (Å)  58.3–2.3 (2.30–2.39) 
Reflections used in refinement  22,331 (453) 
Reflections in test (free) set  1170 (18) 
Rwork  0.266 (0.292) 
Rfree  0.282 (0.246) 
Protein residues  539 
Number of non-hydrogen atoms  4402 
Root mean square deviation   
Bonds length (Å)  0.008 
Bond angle (degrees)  0.93 
Ramachandran favoured* (%)  93.2 
Ramachandran outliers* (%)  0.4 
Rotamer outliers* (%)  0.81 
Clashscore*  1.6 
Average B-factor (Å2)  73.2 
*As reported by Molprobity (65).  
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Table 3. Comparison of the dissociation constants (KD) for WT and mutant A55BB for Cul3. 
Experiments were performed n times and the mean ± SEM is shown. 
Protein Cul3NΔ22 (nM) Cul3N (nM) 
WT 5.3 ± 2.9 (n = 6) < 1 (n = 6) 
F54E 54.7 ± 18.8 (n = 2) 12.0 ± 2.2 (n = 2) 
D99A 119.0 ± 16.0 (n = 2) 5.4 ± 3.7 (n = 2) 
I48A 9.5 ± 1.3 (n = 5) 3.2 ± 0.9 (n = 3) 
I48E n.d.* (n = 2) 73.8 ± 10.3 (n = 3) 
*n.d. = none detected 
 
Table 4. Sequence identities between A55BB and the BB domains of poxvirus orthologues and 
two other VACV BTB-Kelch proteins C2 and F3. 
 Ectromelia 
EVM150 
Cowpox 
A57 
Skunkpox 
WA-176 
Raccoonpox 
Herman-172 
Volepox 
CA-176 
VACV 
C2 
VACV 
F3 
VACV 
A55 95% 98% 79% 77% 75% 25% 23% 
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Figure 1. A55 directly binds to cullin-3 via its N-terminal BB domain. A-C. Representative 
immunoblots following immunoprecipitation (IP) of cleared lysates from HEK293T-REx cell lines (A) 
expressing empty vector (EV), B14-TAP or TAP-A55, the TAP tag comprising STREP and FLAG 
epitopes; (B) expressing B14-TAP or TAP-A55 and transfected with plasmids encoding myc-Cul3 or 
myc-Cul5; (C) expressing EV, B14-TAP, TAP-A55, TAP-A55BB or TAP-A55 Kelch. Cells were lysed 
in (A and C) NP40 or (B) RIPA buffer. Immunoprecipitates were subjected to SDS-PAGE and 
immunoblotting. A and C. FLAG IP and immunoblotting for co-IP of endogenous Cul3. B. Myc IP and 
immunoblotting for co-IP of TAP-tagged B14 or A55. Input, cleared lysate. Data shown are 
representative of at least three independent experiments. Signals arising from the light chain (*) or 
heavy chain (**) of the antibody used for IP are marked. D. SEC-MALS analyses showing the SEC 
elution profiles (thin lines) and molecular mass distribution (thick lines) across the elution peaks for 
A55BB (peak 1, green, theoretical molecular mass 30 kDa, observed molecular mass 60 kDa), 
Cul3NΔ22 (peak 2, blue, theoretical molecular mass 46 kDa, observed molecular mass 45 kDa) and 
A55BB and Cul3NΔ22 together (peak 3, red, theoretical molecular mass 76 kDa, observed molecular 
mass 141 kDa) when eluting from a Superdex 200 10/300 GL column. Peak 4 is assumed to be excess 
Cul3NΔ22. E. Coomassie-stained SDS-PAGE analysis of peaks 1–3 from (D).  
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Figure 2. ITC studies show that A55 binds to Cul3 with nanomolar to sub-nanomolar affinity. A-
D. Representative ITC titration curves showing interactions between A55BB and (A) Cul3NΔ22 or (B) 
Cul3N and between KLHL3, a human BTB related to A55, and (C) Cul3NΔ22 or (D) Cul3N. The top 
figure in each panel shows the baseline-corrected differential power (DP) versus time. The bottom 
figure of each panel is the normalized binding curve showing integrated changes in enthalpy (ΔH) 
against molar ratio. The corresponding dissociation constant (KD), number of binding sites (N), enthalpy 
change (ΔH) and change in Gibbs free energy (ΔG) for each representative experiment are shown. All 
experiments were performed at least twice independently. 
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Figure 3. A55 and cellular BB domains share conserved modes of dimerization and Cul3 binding. 
A. Structure of the A55/Cul3NΔ22 heterodimer in the asymmetric unit as ribbon diagram. Cul3 is in 
cyan and the three domains of A55 (BTB, 3-box and BACK) are in green, orange and grey, respectively. 
Helices α1-α12 from A55 are labelled in black with the exception of α10, which is hidden behind α9 in 
the picture. Helices α1-α16 from Cul3 are labelled in red. B. A55/Cul3 dimer formed by applying 
crystallographic 2-fold symmetry. C. An overlay of three BB/Cul3 complex structures (KLHL3/Cul3, 
PDB code 4HXI (7); KLHL11/Cul3, PDB code 4APF (6); A55/Cul3). The structures are aligned to the 
Cul3 part of the A55/Cul3 complex only. A55, KLHL3, KLHL11 and Cul3 are in green, purple, 
magenta and cyan, respectively, and the three sub-domains are marked. Additional helices at the 
C terminus of the KLHL11 BACK domain are shown as semi-transparent helices. D. Comparison of 
the dimers formed by A55, KLHL3 and KLHL11 BB domains, colored as in (C).   
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Figure 4. Structure-based sequence alignment of the A55, KLHL3 and KLHL11 BB domains. 
Columns are shaded based on amino acid similarity. Secondary structural elements for A55 are shown 
above the aligned sequences and colored as in Fig. 3A. Residues at the A55/Cul3 interface are 
underlined in blue. Residues selected for subsequent mutagenesis studies of A55 are marked by stars at 
the bottom: the two conserved sites (F54 and D56) are marked by purple stars, while the non-conserved 
site (I48) is marked by a red star. Residues from KLHL11 that are involved in Cul3-NTE binding are 
marked by magenta triangles. 
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Figure 5. Conserved and non-conserved interactions at the interface between A55 and Cul3. A. 
The A55BB/Cul3NΔ22 complex structure with two key Cul3 binding sites in the BTB domain boxed 
in black (enlarged in B to F) and red (enlarged in G). B. Structural overlay of the ϕ-X-D/E motifs from 
A55, KLHL3, KLHL11 and SPOP. C-F. Surface of Cul3 colored by residue hydrophobicity from 
yellow (hydrophobic) to white (polar) (70). Hydrophobic binding pockets are shown for F54 of A55, 
M83 of KLHL3, F130 of KLHL11, and M233 of SPOP, which are equivalent to the ϕ residue of the ϕ-
X-D/E motif, and for I48 of A55 and its equivalent residues A77, P124 and A227 in KLHL3, KLHL11 
and SPOP, respectively. G. An overlay of the hydrogen bond formed between Y125 of Cul3 and D99 
of A55 with equivalent residues S128, D181 and D278 in KLHL3, KLHL11 and SPOP, respectively. 
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Figure 6. I48E mutation significantly impairs A55 binding to Cul3. A. Representative thermal melt 
curves of wild-type A55BB and mutants F54E, D99A, I48A and I48E from differential scanning 
fluorimetry (DSF) studies. Curves are offset along the vertical axis for clarity. All experiments were 
performed in triplicate. B. A comparison of the melting temperatures for wild-type A55BB (green), 
F54E (red), D99A (blue), I48A (orange) and I48E (black) mutants. Upper and lower panels display Tm 
values for the first and second melting events, respectively. Error bars show the standard errors of the 
mean from experiments performed in triplicate. C-J. Representative ITC titration curves showing 
binding of A55BB mutants F54E (C, D), D99A (E, F), I48A (G, H) and I48E (I, J) to Cul3NΔ22 and 
Cul3N, respectively. Integrated changes in enthalpy (ΔH) are plotted against molar ratio of titrant. The 
corresponding dissociation constant (KD), number of binding sites (N), enthalpy change (ΔH) and 
change in Gibbs free energy (ΔG) for each representative experiment are shown. All experiments were 
performed at least twice independently. Raw data for (C-J) are shown in Fig. S7.  
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Figure 7. The Cul3-binding residues of A55 are conserved across orthopoxvirus orthologues but 
not in VACV paralogues C2 and F3. Multiple sequence alignment of the A55 BB domains against its 
paralogues from selected poxviruses and two other VACV BTB-Kelch proteins, C2 and F3. Columns 
are shaded based on amino acid similarity. Secondary structural elements for A55 are shown above the 
aligned sequences and colored as in Fig. 3A. Residues at the A55/Cul3 interface are underlined in blue. 
Residues aligned with A55-I48 and the ϕ-X-E motif are boxed in red. 
